Table 2 The 5-fold cross-validation details in the ACP datasets
From: CL-ACP: a parallel combination of CNN and LSTM anticancer peptide recognition model
Fold | Acc(%) | Sens(%) | Spec(%) | Prec(%) | Mcc(%) |
|---|---|---|---|---|---|
ACP736 | |||||
 1 | 83.78 | 84.00 | 83.56 | 84.00 | 67.56 |
 2 | 83.00 | 85.33 | 80.55 | 82.05 | 66.00 |
 3 | 85.03 | 82.67 | 87.50 | 87.32 | 70.19 |
 4 | 84.35 | 86.67 | 81.94 | 83.33 | 68.73 |
 5 | 82.99 | 76.00 | 90.28 | 89.06 | 66.82 |
 Average | 83.83 | 82.93 | 84.76 | 85.15 | 67.86 |
ACP240 | |||||
 1 | 89.58 | 96.15 | 81.82 | 86.21 | 79.45 |
 2 | 81.25 | 92.31 | 68.18 | 77.42 | 63.02 |
 3 | 89.58 | 84.62 | 95.45 | 95.65 | 79.86 |
 4 | 91.67 | 84.62 | 99.89 | 99.89 | 84.62 |
 5 | 87.50 | 96.00 | 78.26 | 82.76 | 75.86 |
 Average | 87.92 | 90.74 | 84.76 | 88.41 | 76.56 |
ACP539 | |||||
 1 | 87.04 | 81.58 | 90.00 | 81.58 | 71.58 |
 2 | 80.56 | 65.79 | 88.57 | 75.76 | 56.36 |
 3 | 83.33 | 74.37 | 88.41 | 78.38 | 63.52 |
 4 | 89.81 | 84.62 | 92.75 | 86.84 | 77.82 |
 5 | 81.31 | 81.08 | 81.43 | 69.77 | 60.64 |
 Average | 84.41 | 77.48 | 88.23 | 78.46 | 65.98 |